
Gene knockout cell lines are generated using CRISPR-Cas9 based technology to precisely disrupt target genes, enabling functional genomics research, disease modeling, and target validation.
ZNF460 (zinc finger protein 460) encodes a zinc finger protein containing conserved zinc-coordinating domains characteristic of the Kruppel-related zinc finger family. Zinc finger proteins commonly interact with DNA or RNA and can function in transcriptional regulation or other nucleic acid-dependent processes. The available annotation does not establish specific molecular targets or biological functions for ZNF460, so its precise cellular role remains incompletely characterized.
The Ishikawa cell line was established from an endometrial adenocarcinoma of a 39-year-old female patient. This human endometrial cancer model exhibits tumorigenic properties, forming well-differentiated adenocarcinomas in athymic nude mice. Ishikawa cells express estrogen and progesterone receptors both in vitro and in induced tumors, and they respond to steroid hormone stimulation. The cells have also been reported to produce corticotropin-releasing hormone, placental alkaline phosphatase, and chorionic gonadotropin. Ishikawa is widely used as a model for studying endometrial cancer biology, hormone receptor signaling, reproductive endocrinology, and endocrine-based therapeutic research.
Each knockout cell line is validated by STR authentication, sterility testing (bacteria/fungi), and mycoplasma screening. Genotype is confirmed by two rounds of PCR and Sanger sequencing. Only clones that pass all QC criteria are released, ensuring reliable identity and performance for downstream applications.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Targeted knockout region: EExon 3
Reference Transcript: NM_006635
Frameshift Mutation Strategy
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use





Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?